BACKGROUND: Predictors of hospitalisation in people with HIV (PLHIV) in the contemporary treatment era are not well understood. METHODS: This ASTRA sub-study used clinic data linkage and record review to determine occurrence of hospitalisations among 798 PLHIV from baseline questionnaire (February to December 2011) until 1 June 2018. Associations of baseline social circumstance, socioeconomic, lifestyle, mental health, demographic and clinical factors with repeated all-cause hospitalisation from longitudinal data were investigated using Prentice-Williams-Peterson models. Associations were also assessed in 461 individuals on antiretroviral therapy (ART) with viral load ≤50 copies/ml and CD4 count ≥500 cells/ µl. FINDINGS: Rate of hospitalisation was 5.8/100 person-years (95% CI: 5.1-6.5). Adjusted for age, demographic group and time with diagnosed HIV, the following social circumstance, socioeconomic, lifestyle and mental health factors predicted hospitalisation: no stable partner (adjusted hazard ratio (aHR)=1.59; 95% CI=1.16-2.20 vs living with partner); having children (aHR=1.50; 1.08-2.10); non-employment (aHR=1.56; 1.07-2.27 for unemployment; aHR=2.39; 1.70-3.37 for sick/disabled vs employed); rented housing (aHR=1.72; 1.26-2.37 vs homeowner); not enough money for basic needs (aHR=1.82; 1.19-2.78 vs enough); current smoking (aHR=1.39; 1.02-1.91 vs never); recent injection-drug use (aHR=2.11; 1.30-3.43); anxiety symptoms (aHRs=1.39; 1.01-1.91, 2.06; 1.43-2.95 for mild and moderate vs none/minimal); depressive symptoms (aHRs=1.67; 1.17-2.38, 1.91; 1.30-2.78 for moderate and severe vs none/minimal); treated/untreated depression (aHRs=1.65; 1.03-2.64 for treated depression only, 1.87; 1.39-2.52 for depressive symptoms only; 1.53; 1.05-2.24; for treated depression and depressive symptoms, versus neither). Associations were broadly similar in those with controlled HIV and high CD4. INTERPRETATION: Social circumstance, socioeconomic disadvantage, adverse lifestyle factors and poorer mental health are strong predictors of hospitalisation in PLHIV, highlighting the need for targeted interventions and care. FUNDING: British HIV Association (BHIVA) Research Award (2017); SMR funded by a PhD fellowship from the Royal Free Charity.
BACKGROUND: Predictors of hospitalisation in people with HIV (PLHIV) in the contemporary treatment era are not well understood. METHODS: This ASTRA sub-study used clinic data linkage and record review to determine occurrence of hospitalisations among 798 PLHIV from baseline questionnaire (February to December 2011) until 1 June 2018. Associations of baseline social circumstance, socioeconomic, lifestyle, mental health, demographic and clinical factors with repeated all-cause hospitalisation from longitudinal data were investigated using Prentice-Williams-Peterson models. Associations were also assessed in 461 individuals on antiretroviral therapy (ART) with viral load ≤50 copies/ml and CD4 count ≥500 cells/ µl. FINDINGS: Rate of hospitalisation was 5.8/100 person-years (95% CI: 5.1-6.5). Adjusted for age, demographic group and time with diagnosed HIV, the following social circumstance, socioeconomic, lifestyle and mental health factors predicted hospitalisation: no stable partner (adjusted hazard ratio (aHR)=1.59; 95% CI=1.16-2.20 vs living with partner); having children (aHR=1.50; 1.08-2.10); non-employment (aHR=1.56; 1.07-2.27 for unemployment; aHR=2.39; 1.70-3.37 for sick/disabled vs employed); rented housing (aHR=1.72; 1.26-2.37 vs homeowner); not enough money for basic needs (aHR=1.82; 1.19-2.78 vs enough); current smoking (aHR=1.39; 1.02-1.91 vs never); recent injection-drug use (aHR=2.11; 1.30-3.43); anxiety symptoms (aHRs=1.39; 1.01-1.91, 2.06; 1.43-2.95 for mild and moderate vs none/minimal); depressive symptoms (aHRs=1.67; 1.17-2.38, 1.91; 1.30-2.78 for moderate and severe vs none/minimal); treated/untreated depression (aHRs=1.65; 1.03-2.64 for treated depression only, 1.87; 1.39-2.52 for depressive symptoms only; 1.53; 1.05-2.24; for treated depression and depressive symptoms, versus neither). Associations were broadly similar in those with controlled HIV and high CD4. INTERPRETATION: Social circumstance, socioeconomic disadvantage, adverse lifestyle factors and poorer mental health are strong predictors of hospitalisation in PLHIV, highlighting the need for targeted interventions and care. FUNDING: British HIV Association (BHIVA) Research Award (2017); SMR funded by a PhD fellowship from the Royal Free Charity.
Authors: T Rinda Soong; Julianna J Jung; Gabor D Kelen; Richard E Rothman; Avanthi Burah; Judy B Shahan; Yu-Hsiang Hsieh Journal: Am J Emerg Med Date: 2012-01-12 Impact factor: 2.469
Authors: R Seng; P Mutuon; J Riou; C Duvivier; L Weiss; J D Lelievre; L Meyer; D Vittecoq; O Zak Dit Zbar; J Frenkiel; M Frank-Soltysiak; F Boue; C Rapp; A Sobel; G Brucker; C Goujard; D Salmon Journal: Rev Epidemiol Sante Publique Date: 2017-12-10 Impact factor: 1.019
Authors: Thibaut Davy-Mendez; Sonia Napravnik; David A Wohl; Amy L Durr; Oksana Zakharova; Claire E Farel; Joseph J Eron Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Trevor A Crowell; Stephen A Berry; John A Fleishman; Richard W LaRue; Philip T Korthuis; Ank E Nijhawan; Richard D Moore; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2015-04-01 Impact factor: 3.731
Authors: Sheri D Weiser; Abigail Hatcher; Edward A Frongillo; David Guzman; Elise D Riley; David R Bangsberg; Margot B Kushel Journal: J Gen Intern Med Date: 2012-08-18 Impact factor: 5.128
Authors: J A McGowan; L Sherr; A J Rodger; M Fisher; A Miners; J Anderson; M A Johnson; J Elford; S Collins; G Hart; A N Phillips; A Speakman; F C Lampe Journal: HIV Med Date: 2016-07-07 Impact factor: 3.180
Authors: Andrew Speakman; Alison Rodger; Andrew N Phillips; Richard Gilson; Margaret Johnson; Martin Fisher; Jane Anderson; Rebecca O'Connell; Monica Lascar; Kazeem Aderogba; Simon Edwards; Jeffrey McDonnell; Nicky Perry; Lorraine Sherr; Simon Collins; Graham Hart; Anne M Johnson; Alec Miners; Jonathan Elford; Anna-Maria Geretti; William J Burman; Fiona C Lampe Journal: PLoS One Date: 2013-10-15 Impact factor: 3.240
Authors: Sophia M Rein; Fiona C Lampe; Clinton Chaloner; Adam Stafford; Alison J Rodger; Margaret A Johnson; Jeffrey McDonnell; Fiona Burns; Sara Madge; Alec Miners; Lorraine Sherr; Simon Collins; Andrew Speakman; Andrew N Phillips; Colette J Smith Journal: BMC Infect Dis Date: 2021-04-29 Impact factor: 3.090
Authors: Timothy P W Jones; Fiona C Lampe; Alejandro Arenas-Pinto; Colette Smith; Jeff McDonnell; Lewis Haddow; Margaret Johnson; Elaney Yousef; Monica Lascar; Anna Maria Geretti; Lorraine Sherr; Simon Collins; Andrew N Phillips; Alison J Rodger Journal: HIV Med Date: 2021-10-11 Impact factor: 3.094